These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 2567039)

  • 1. Serotonin-1A anxiolytics: an overview.
    Feighner JP; Boyer WF
    Psychopathology; 1989; 22 Suppl 1():21-6. PubMed ID: 2567039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Buspirone and related compounds as alternative anxiolytics.
    Taylor DP; Moon SL
    Neuropeptides; 1991 Jul; 19 Suppl():15-9. PubMed ID: 1679210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The 5-HT1A receptor: a new effective principle in psychopharmacologic therapy?].
    Davids E; Lesch KP
    Fortschr Neurol Psychiatr; 1996 Nov; 64(11):460-72. PubMed ID: 9064274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The new generation of serotonergic anxiolytics: possible clinical roles.
    Eison MS
    Psychopathology; 1989; 22 Suppl 1():13-20. PubMed ID: 2567037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of generalized anxiety: new pharmacologic approaches].
    Boulenger JP
    Encephale; 1995; 21(6):459-66. PubMed ID: 8674471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Azapirones: history of development.
    Eison AS
    J Clin Psychopharmacol; 1990 Jun; 10(3 Suppl):2S-5S. PubMed ID: 1973936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonbenzodiazepine anxiolytics: clinical usefulness.
    Rickels K
    J Clin Psychiatry; 1983 Nov; 44(11 Pt 2):38-44. PubMed ID: 6139368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pharmacology of anxiolytics and their therapeutic use].
    Tada K
    Ryoikibetsu Shokogun Shirizu; 2003; (38):608-11. PubMed ID: 12877061
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment of generalized anxiety disorder.
    Gorman JM
    J Clin Psychiatry; 2002; 63 Suppl 8():17-23. PubMed ID: 12044104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serotonergic anxiolytics and treatment of depression.
    Robinson DS; Alms DR; Shrotriya RC; Messina M; Wickramaratne P
    Psychopathology; 1989; 22 Suppl 1():27-36. PubMed ID: 2657837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Azapirones: an alternative to benzodiazepines for anxiety.
    Cadieux RJ
    Am Fam Physician; 1996 May; 53(7):2349-53. PubMed ID: 8638511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use and development of anxiolytics in Japan.
    Yamawaki S
    Eur Neuropsychopharmacol; 1999 Dec; 9 Suppl 6():S413-9. PubMed ID: 10622688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Azaspirodecanodiones in clinical psychiatry].
    Conde López V; Martínez Roig M
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1992; 20(4):155-67. PubMed ID: 1356293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacologic treatments effective in both generalized anxiety disorder and major depressive disorder: clinical and theoretical implications.
    Casacalenda N; Boulenger JP
    Can J Psychiatry; 1998 Sep; 43(7):722-30. PubMed ID: 9773222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prior benzodiazepine use and buspirone response in the treatment of generalized anxiety disorder.
    DeMartinis N; Rynn M; Rickels K; Mandos L
    J Clin Psychiatry; 2000 Feb; 61(2):91-4. PubMed ID: 10732655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Establishing the maximum tolerated dose of lesopitron in patients with generalized anxiety disorder: a bridging study.
    Sramek JJ; Fresquet A; Marion-Landais G; Hourani J; Jhee SS; Martinez L; Jensen CM; Bolles K; Carrington AT; Cutler NR
    J Clin Psychopharmacol; 1996 Dec; 16(6):454-8. PubMed ID: 8959472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short-term tolerability of a nonazapirone selective serotonin 1A agonist in adults with generalized anxiety disorder: a 28-day, open-label study.
    Mathew SJ; Garakani A; Reinhard JF; Oshana S; Donahue S
    Clin Ther; 2008 Sep; 30(9):1658-66. PubMed ID: 18840371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generalised anxiety disorder: treatment options.
    Sramek JJ; Zarotsky V; Cutler NR
    Drugs; 2002; 62(11):1635-48. PubMed ID: 12109925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A phase II multicenter dose-finding, efficacy and safety trial of ipsapirone in outpatients with generalized anxiety disorder.
    Cutler NR; Hesselink JM; Sramek JJ
    Prog Neuropsychopharmacol Biol Psychiatry; 1994 May; 18(3):447-63. PubMed ID: 7915845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imipramine and buspirone in treatment of patients with generalized anxiety disorder who are discontinuing long-term benzodiazepine therapy.
    Rickels K; DeMartinis N; García-España F; Greenblatt DJ; Mandos LA; Rynn M
    Am J Psychiatry; 2000 Dec; 157(12):1973-9. PubMed ID: 11097963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.